logoTry Persana

Insilico Medicine - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Insilico Medicine including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Insilico Medicine company logo

AI-driven drug discovery company revolutionizing treatment development.

Insilico Medicine is a clinical-stage biotechnology company using generative AI for drug discovery, focusing on developing treatments for various diseases including cancer and fibrosis.

HeadquartersHong Kong, China
Team size51-100
Founded2014

What is Insilico Medicine? - Company Overview & Details

Insilico Medicine is Insilico Medicine is a clinical-stage biotechnology company using generative AI for drug discovery, focusing on developing treatments for various diseases including cancer and fibrosis. Founded in 2014, the company is headquartered in Hong Kong, China.

Who Founded Insilico Medicine?

Insilico Medicine was founded by Alex Zhavoronkov.

Who are the Key Executives at Insilico Medicine? - Leadership Team

Insilico Medicine is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Insilico Medicine

Alex ZhavoronkovCEO

Chief Technology Officer (CTO) of Insilico Medicine

Feng RenCTO

About Alex Zhavoronkov - CEO of Insilico Medicine

Alex Zhavoronkov serves as the Chief Executive Officer of Insilico Medicine, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Insilico Medicine Company Details & Key Information

Where is Insilico Medicine located?

Insilico Medicine is headquartered in Hong Kong, China.

How many employees does Insilico Medicine have?

Insilico Medicine has 51-100 employees.

When was Insilico Medicine founded?

Insilico Medicine was founded in 2014.

Insilico Medicine Official Website

How much funding has Insilico Medicine raised?

Insilico Medicine has raised $400 million across 5 funding rounds. The most recent funding was completed on 2022-08-01.

Funding Overview

Insilico Medicine has raised significant funds including a $255 million Series C round to expand its drug discovery capabilities and AI technology.

$400 million
Total Funding Raised
5
Funding Rounds
2022-08-01
Latest Round

Insilico Medicine Funding History

Series D
2022-08-01
$95 million
Series C
2021-06-01
$255 million

Who are the key investors in Insilico Medicine?

Insilico Medicine is backed by 2 key investors including Warburg Pincus, Prosperity7 Ventures. These investors focus on Biotechnology, Pharmaceuticals, Healthcare sectors.

Insilico Medicine Investor Overview

2
Key Investors
4
Focus Areas
2
Notable Investments

Complete List of Insilico Medicine Investors

Warburg Pincus

A leading global private equity firm focused on growth investing.

Investment Focus
Biotechnology
Pharmaceuticals
Notable Portfolio Companies
$255 million in Series C financing

Prosperity7 Ventures

Saudi Aramco’s venture capital firm investing in innovative technologies.

Investment Focus
Healthcare
Technology
Notable Portfolio Companies
$35 million in Series D financing

What sectors do Insilico Medicine investors focus on?

The investors backing Insilico Medicine primarily focus on Biotechnology, Pharmaceuticals, Healthcare, Technology sectors.

Biotechnology
Pharmaceuticals
Healthcare
Technology

Featured Investor: Warburg Pincus

Warburg Pincus

A leading global private equity firm focused on growth investing.

Notable Investments: $255 million in Series C financing

What are Insilico Medicine's future plans?

Insilico Medicine Insilico Medicine plans to further develop its AI capabilities and expand its drug pipeline.

Insilico Medicine Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Insilico Medicine face?

Insilico Medicine has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Insilico Medicine

1

High competition in biotech

2

Regulatory approval processes

What opportunities does Insilico Medicine have?

Insilico Medicine has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Insilico Medicine

1

Expanding global partnerships

2

Utilizing AI for faster drug development

Insilico Medicine Strategic Position Summary

Key Focus Areas

Insilico Medicine is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Insilico Medicine?

Insilico Medicine has 2 recent news updates covering key business developments and market activities.

Insilico Medicine News Overview

2
Recent Articles
Active
Media Coverage
2023-06-29
Latest Update

What is Insilico Medicine in the news for?

Insilico Medicine is currently featured in news for Insilico Medicine, Inc. goes public. and other significant business developments.

Recent News Articles About Insilico Medicine

Article 1
2023-06-29

Insilico Medicine, Inc. goes public.

Insilico Medicine considers a U.S. IPO aiming to raise about $300 million with a focus on innovative drug discovery.

BNN Bloomberg
Read News
Article 2
2023-01-10

Insilico Medicine, Inc. partners with Centogene AG.

Insilico announces a strategic partnership with Centogene to tackle rare diseases using its AI-driven platform.

Inside Precision Medicine
Read News

Insilico Medicine FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Insilico Medicine including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Insilico Medicine Questions & Answers - Company Information

Q1

What is Insilico Medicine?

Insilico Medicine is a clinical-stage biotechnology company using generative AI for drug discovery, focusing on developing treatments for various diseases including cancer and fibrosis.

Q2

Who founded Insilico Medicine?

Insilico Medicine was founded by Alex Zhavoronkov.

Q3

Who is the CEO of Insilico Medicine?

The CEO of Insilico Medicine is Alex Zhavoronkov. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Insilico Medicine raised?

Insilico Medicine has raised a total of $$400 million across 5 funding rounds. The most recent funding was completed on 2022-08-01.

Q5

Who are the investors in Insilico Medicine?

Insilico Medicine's key investors include Warburg Pincus, Prosperity7 Ventures.

Q6

Where is Insilico Medicine headquartered?

Insilico Medicine is headquartered in Hong Kong, China.

Q7

When was Insilico Medicine founded?

Insilico Medicine was founded in 2014.

Q8

How many employees does Insilico Medicine have?

Insilico Medicine has 51-100 employees.

Q9

What is Insilico Medicine's official website?

You can visit Insilico Medicine's official website at https://insilico.com/.

Q10

What was Insilico Medicine's latest funding round?

Insilico Medicine's latest funding round was a Series D round of $$95 million completed on 2022-08-01.

Q11

Who is founder?

Alex Zhavoronkov

Q12

Who is cto?

Feng Ren

Q13

What does the company do?

Insilico Medicine develops innovative drugs using AI technology for various diseases.

Q14

How much funding?

$400 million

Q15

Latest funding date?

2022-08-01

Q16

Who are the investors?

Warburg Pincus Prosperity7 Ventures

Q17

What are the challenges?

High competition in biotech Regulatory approval processes

Q18

What are the opportunities?

Expanding global partnerships Utilizing AI for faster drug development

Q19

Latest news?

Insilico Medicine considers a U.S. IPO aiming to raise about $300 million with a focus on innovative drug discovery. Insilico announces a strategic partnership with Centogene to tackle rare diseases using its AI-driven platform.

More Information About Insilico Medicine

For additional details about Insilico Medicine, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.